NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

I thought that was very strange. Until a few days ago, EDEN and Flaskworks were the magic bullet that was to handle all the large volume beyond the UK that the manual method could not. Its development was to be where the eventual billions in revenue would stream from as the US, EU, Japan and the rest of the world, when they were to adopt DCVAX as the SOC for solid tumors etc. Then out of the blue, we were told EDEN could not handle this volume, but it was the "better" more industrial ORI that would handle the really high volumes pushing aside EDEN etc??? This really took me by surprise and I cautiously awaited more news, but it sounded very suspect and sudden.
I am glad you explained the difference between ORI and EDEN and that ORI is NOT the replacement for EDEN which still hopefully does the high volume job well and will work as per our expectations. This little episode scares me a bit as it shows how readily people can be fooled to believe almost anything with very little effort.